{
    "clinical_study": {
        "@rank": "85889", 
        "arm_group": [
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Subjects inhale 100% oxygen"
            }, 
            {
                "arm_group_label": "30% N2O", 
                "arm_group_type": "Active Comparator", 
                "description": "Subjects inhale 30% N2O"
            }, 
            {
                "arm_group_label": "0.2% isoflurane", 
                "arm_group_type": "Active Comparator", 
                "description": "Subjects inhale 0.2% isoflurane"
            }, 
            {
                "arm_group_label": "0.4% isoflurane", 
                "arm_group_type": "Active Comparator", 
                "description": "Subjects inhale 0.4% isoflurane"
            }, 
            {
                "arm_group_label": "0.2% isoflurane + 30% N2O", 
                "arm_group_type": "Active Comparator", 
                "description": "Subjects will inhale a combination of 0.2% isoflurane and 30% N2O"
            }, 
            {
                "arm_group_label": "0.4% isoflurane + 30% N2O", 
                "arm_group_type": "Active Comparator", 
                "description": "Subjects will inhale a combination of 0.4% isoflurane and 30% N2O"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to conduct experiments to examine subjective and reinforcing\n      effects of nitrous oxide.  Mood altering and psychomotor effects will be tested on non-drug\n      abusers and preference procedures will be used to assess reinforcing effects.  To evaluate\n      the acute and residual effects of subanesthetic concentrations of isoflurane/nitrous oxide\n      combinations in healthy volunteers."
        }, 
        "brief_title": "Effects of Subanesthetic Concentrations of Isoflurane/Nitrous Oxide - 3", 
        "completion_date": {
            "#text": "January 1996", 
            "@type": "Actual"
        }, 
        "condition": [
            "Opioid-Related Disorders", 
            "Substance-Related Disorders"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Opioid-Related Disorders", 
                "Substance-Related Disorders"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Please contact site for information."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "32 Years", 
            "minimum_age": "21 Years"
        }, 
        "enrollment": {
            "#text": "10", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "September 20, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00000251", 
            "org_study_id": "NIDA-08391-3", 
            "secondary_id": [
                "R01DA008391", 
                "R01-08391-3"
            ]
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "30% N2O", 
                    "0.2% isoflurane + 30% N2O", 
                    "0.4% isoflurane + 30% N2O"
                ], 
                "intervention_name": "30% N2O", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "0.2% isoflurane", 
                    "0.2% isoflurane + 30% N2O"
                ], 
                "intervention_name": "0.2% isoflurane", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "0.4% isoflurane", 
                    "0.4% isoflurane + 30% N2O"
                ], 
                "intervention_name": "0.4% isoflurane", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Isoflurane", 
                "Nitrous Oxide"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "lastchanged_date": "July 23, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Chicago", 
                    "country": "United States", 
                    "state": "Illinois", 
                    "zip": "60637"
                }, 
                "name": "University of Chicago, Anesthesia & Critical Care"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "6", 
        "official_title": "Effects of Subanesthetic Concentrations of Isoflurane/Nitrous Oxide", 
        "overall_official": {
            "affiliation": "University of Chicago", 
            "last_name": "James Zacny, Ph.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "January 1996", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "measure": "Logical reasoning test", 
                "safety_issue": "No", 
                "time_frame": "15 & 30 min inhalation and 5, 30, & 60 min post inhalation"
            }, 
            {
                "measure": "Free recall memory test", 
                "safety_issue": "No", 
                "time_frame": "15 & 30 min inhalation and 5, 30, & 60 min post inhalation"
            }, 
            {
                "measure": "Auditory reaction time", 
                "safety_issue": "No", 
                "time_frame": "15 & 30 min inhalation and 5,30 & 60 min post inhalation"
            }, 
            {
                "measure": "Digit symbol substitution test", 
                "safety_issue": "No", 
                "time_frame": "2,15 & 30 min inhalation and 5,30 & 60 min post inhalation"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00000251"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "University of Chicago", 
        "sponsors": {
            "collaborator": {
                "agency": "National Institute on Drug Abuse (NIDA)", 
                "agency_class": "NIH"
            }, 
            "lead_sponsor": {
                "agency": "University of Chicago", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 1994", 
        "study_design": "Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "July 2013"
    }, 
    "geocoordinates": {
        "University of Chicago, Anesthesia & Critical Care": "41.878 -87.63"
    }
}